Detecting Fraud, Waste and Abuse in Laboratory Testing

Presented by

Gerry Petrowski and Suzanne Baker, General Dynamics Health Solutions

About this talk

Urine drug screening and genetic testing are ongoing areas of concern for fraud, waste and abuse (FWA) investigators. This session will familiarize investigators with common schemes found in laboratory claims data and provide effective methods for detecting, preventing and responding to healthcare fraud. Additionally, this webinar will examine documentation requirements to support payments for drug screenings, as well as review the key components necessary to conduct a thorough medical review and to write a clear, concise audit findings report.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (18)
Subscribers (1054)
General Dynamics Health Solutions, part of General Dynamics Information Technology, provides end-to-end solutions and professional services to health organizations in the defense, federal civilian government, state and local government, commercial and international sectors. Headquartered in Fairfax, Va., with major offices worldwide, company capabilities include Health Data Management and Analytics, Multi-Channel Health Communications, Health Facility Outfitting and Logistics, Clinical Staffing and Medical Research Services, Healthcare Administrative Services, and IT Services and Infrastructure.